Cecilia C Garcia1, Bárbara Piotrkowski2,3, Plácida Baz1, Daniel Poncino4, Javier Benavides5, Luis Colombato5, María Laura Reyes Toso6,7, Silvina Yantorno6,7, Valeria Descalzi6,7, Gabriel E Gondolesi6,7, Cesar G Fraga2,3, Alejandra C Cherñavsky8. 1. Facultad de Farmacia Y Bioquímica, Instituto de Inmunología, Genética Y Metabolismo (INIGEM), CONICET-Universidad de Buenos Aires, Hospital de Clínicas José de San Martín, Avda. Córdoba 2351 (1120) CABA, Buenos Aires, Argentina. 2. Facultad de Farmacia Y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. 3. Instituto de Bioquímica Y Medicina Molecular (IBIMOL), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina. 4. Sección Hepatología, Servicio de Gastroenterología, Sanatorio Dr. Julio Méndez, Buenos Aires, Argentina. 5. Sección Hepatología, Servicio de Gastroenterología, Hospital Británico de Buenos Aires, Buenos Aires, Argentina. 6. Unidad de Hepatología, Cirugía Hepatobiliar Y Trasplante Hepático, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina. 7. Instituto de Medicina Traslacional, Trasplante Y Bioingeniería, Universidad Fundación Favaloro, Buenos Aires, Argentina. 8. Facultad de Farmacia Y Bioquímica, Instituto de Inmunología, Genética Y Metabolismo (INIGEM), CONICET-Universidad de Buenos Aires, Hospital de Clínicas José de San Martín, Avda. Córdoba 2351 (1120) CABA, Buenos Aires, Argentina. alejandra.cher@yahoo.com.ar.
Abstract
BACKGROUND: Deregulation of immune response and oxidative stress contribute to nonalcoholic fatty liver disease (NAFLD) pathogenesis. Resistin is a physiological modulator of inflammation and redox homeostasis of different cell types. Increased resistin serum concentration and the direct association between resistin hepatic expression and NAFLD severity suggest that resistin participates in NAFLD pathogenesis. AIMS: To evaluate resistin-induced regulation of redox homeostasis in mononuclear leukocytes from NAFLD patients and controls. METHODS: We evaluated basal and resistin-mediated modulation of reactive oxygen species (ROS) and glutathione content by flow cytometry, and antioxidant enzyme activities by spectrophotometry. RESULTS: Peripheral blood mononuclear cells (PBMC) from NAFLD patients showed higher ROS content and glutathione peroxidase activity and lower glutathione content, superoxide dismutase and glutathione reductase activities than control PBMC. Resistin decreased ROS levels and superoxide dismutase activity and increased glutathione reductase and catalase activities in PBMC from controls but not from patients. Resistin decreased glutathione content in PBMC from control and NAFLD patients, with greater effect on patient cells. Basal and resistin-modulated ROS levels were directly associated with obesity-related risk factors for NAFLD. Hepatic myeloid cells and T-lymphocytes from NAFLD patients showed higher basal ROS content than cells from controls. Resistin decreased ROS levels in hepatic T-lymphocytes from controls but not from patients. CONCLUSIONS: Resistin regulates redox homeostasis in mononuclear leukocytes. A decreased response to resistin in leukocytes from NAFLD patients is associated with an impaired redox homeostasis.
BACKGROUND: Deregulation of immune response and oxidative stress contribute to nonalcoholic fatty liver disease (NAFLD) pathogenesis. Resistin is a physiological modulator of inflammation and redox homeostasis of different cell types. Increased resistin serum concentration and the direct association between resistin hepatic expression and NAFLD severity suggest that resistin participates in NAFLD pathogenesis. AIMS: To evaluate resistin-induced regulation of redox homeostasis in mononuclear leukocytes from NAFLD patients and controls. METHODS: We evaluated basal and resistin-mediated modulation of reactive oxygen species (ROS) and glutathione content by flow cytometry, and antioxidant enzyme activities by spectrophotometry. RESULTS: Peripheral blood mononuclear cells (PBMC) from NAFLD patients showed higher ROS content and glutathione peroxidase activity and lower glutathione content, superoxide dismutase and glutathione reductase activities than control PBMC. Resistin decreased ROS levels and superoxide dismutase activity and increased glutathione reductase and catalase activities in PBMC from controls but not from patients. Resistin decreased glutathione content in PBMC from control and NAFLD patients, with greater effect on patient cells. Basal and resistin-modulated ROS levels were directly associated with obesity-related risk factors for NAFLD. Hepatic myeloid cells and T-lymphocytes from NAFLD patients showed higher basal ROS content than cells from controls. Resistin decreased ROS levels in hepatic T-lymphocytes from controls but not from patients. CONCLUSIONS: Resistin regulates redox homeostasis in mononuclear leukocytes. A decreased response to resistin in leukocytes from NAFLD patients is associated with an impaired redox homeostasis.
Authors: Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal Journal: Gastroenterology Date: 2012-05-15 Impact factor: 22.682
Authors: Vera Francisco; Maria Jesus Sanz; José T Real; Patrice Marques; Maurizio Capuozzo; Djedjiga Ait Eldjoudi; Oreste Gualillo Journal: Biology (Basel) Date: 2022-08-19